Top 19 Aragon Pharmaceuticals investors
The most complete profiles first. Showing 19 of 19.
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
David GoeddelVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Peter SvennilsonVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Richard GasterVerified
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Sunny ReddyVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Aftab KheraniVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Andrew SchiffVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 60 more
Verified email available
David PezeshkiVerified
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Verified email available
Eric AguiarVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Josh BilenkerVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Robert WenzelVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Verified email available
Aaron Royston, M.D.
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, HistoWiz and 35 more
Contact details available
Jaume Pons
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
Tim Kutzkey
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Yvonne Yamanaka
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareWomen FoundedLife ScienceManufacturingPortfolio: Attralus, Aurinia Pharmaceuticals, Labrys Biologics, Adaptimmune and 33 more
Contact details available
JJ Kang
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
James Evangelista
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Scott Braunstein
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
Sophie Phillips
Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Zeltiq Aesthetics, Dermira, Spruce Biosciences, Syros Pharmaceuticals and 56 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
- Seragon Pharmaceuticals18
- Arcus Biosciences14
- VYNE Therapeutics13
- Elevation Oncology13
- Cidara Therapeutics13
- Cytos13
- Aimmune Therapeutics9
- Verona Pharma9
- Spruce Biosciences8
- Roka Bioscience8
- Promentis Pharmaceuticals8
Frequently asked questions
How many Aragon Pharmaceuticals investors are on Angel Roster?
Angel Roster lists 19 Aragon Pharmaceuticals investors. 11 of them (58%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (17), Private Equity Firms (16) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Aragon Pharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (5) and Series B (4).
Where are Aragon Pharmaceuticals investors based?
Most are based in the United States (19).
Which companies have Aragon Pharmaceuticals investors backed?
The most-backed portfolio companies among them are Seragon Pharmaceuticals (18), Arcus Biosciences (14), VYNE Therapeutics (13), Elevation Oncology (13) and Cidara Therapeutics (13).
How do I contact Aragon Pharmaceuticals investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.